Skip to main content
. 2015 Nov 29;62(5):655–663. doi: 10.1093/cid/civ963

Figure 2.

Figure 2.

Prevalence of transmitted drug resistance (TDR) among different transmission risk groups (men who have sex with men [MSM], heterosexuals [HSX], and injecting drug users [IDUs]) and subtypes, for nucleoside reverse transcriptase inhibitors (NRTIs), nonnucleoside reverse transcriptase inhibitors (NNRTIs), and protease inhibitors (PIs).